...
首页> 外文期刊>Journal of immunology research. >Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of Candida glabrata : An Immunoinformatics Approach
【24h】

Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of Candida glabrata : An Immunoinformatics Approach

机译:基于表位的肽疫苗设计对念珠菌的果糖二磷酸蛋白蛋白酶 - 一种免疫信息方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background . Candida glabrata is a human opportunistic pathogen that can cause life-threatening systemic infections. Although there are multiple effective vaccines against fungal infections and some of these vaccines are engaged in different stages of clinical trials, none of them have yet been approved by the FDA. Aim . Using immunoinformatics approach to predict the most conserved and immunogenic B- and T-cell epitopes from the fructose bisphosphate aldolase (Fba1) protein of C. glabrata . Material and Method . 13 C. glabrata fructose bisphosphate aldolase protein sequences (361 amino acids) were retrieved from NCBI and presented in several tools on the IEDB server for prediction of the most promising epitopes. Homology modeling and molecular docking were performed. Result . The promising B-cell epitopes were AYFKEH, VDKESLYTK, and HVDKESLYTK, while the promising peptides which have high affinity to MHC I binding were AVHEALAPI, KYFKRMAAM, QTSNGGAAY, RMAAMNQWL, and YFKEHGEPL. Two peptides, LFSSHMLDL and YIRSIAPAY, were noted to have the highest affinity to MHC class II that interact with 9 alleles. The molecular docking revealed that the epitopes QTSNGGAAY and LFSSHMLDL have the lowest binding energy to MHC molecules. Conclusion . The epitope-based vaccines predicted by using immunoinformatics tools have remarkable advantages over the conventional vaccines in that they are more specific, less time consuming, safe, less allergic, and more antigenic. Further in vivo and in vitro experiments are needed to prove the effectiveness of the best candidate’s epitopes (QTSNGGAAY and LFSSHMLDL). To the best of our knowledge, this is the first study that has predicted B- and T-cell epitopes from the Fba1 protein by using in silico tools in order to design an effective epitope-based vaccine against C. glabrata .
机译:背景 。光滑念珠菌是人体条件致病菌,可导致危及生命的全身性感染。虽然有对真菌感染多种有效的疫苗和一些这些疫苗都是从事临床试验的不同阶段,他们都没有尚未被FDA批准。目的 。使用免疫信息学方法来从所述果糖二磷酸醛缩酶(FBA1)光滑念珠菌的蛋白预测最保守的和免疫原性B-和T-细胞表位。材料和方法。 13点光滑念珠菌果糖磷酸醛缩酶蛋白的序列(361个氨基酸)从NCBI检索和IEDB服务器为最有希望的表位的预测在几个工具呈现。进行同源建模和分子对接。结果 。有希望的B细胞表位是AYFKEH,VDKESLYTK,和HVDKESLYTK,而有前途的肽,其具有高亲和力MHC I结合是AVHEALAPI,KYFKRMAAM,QTSNGGAAY,RMAAMNQWL,和YFKEHGEPL。二肽,LFSSHMLDL和YIRSIAPAY,被指出有亲和力最高的MHC类型II互相作用与9个等位基因。分子对接,发现该表位和QTSNGGAAY LFSSHMLDL具有最低的结合能与MHC分子。结论 。通过免疫信息学工具预测基于表位疫苗具有比常规疫苗显着的优点,因为它们更具体的,耗时少,安全性高,过敏反应少,更多的抗原。此外,在体内和体外实验需要证明的最佳候选的表位(QTSNGGAAY和LFSSHMLDL)的有效性。据我们所知,这是一个已经通过,以设计针对光滑念珠菌有效的基于表位的疫苗使用,在硅片工具预测从FBA1蛋白质B细胞和T细胞表位的第一项研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号